VVOS · Vivos Therapeutics, Inc. · Analyst Estimates
$0.13
0.00 (-1.80%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had approximately $1.8 million in cash and cash equivalents, which will not be sufficient to fund operations and strategic objectives over the next twelve months from the date of the issuance of these financial statements. Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.61M
Shares
20.12M
Volume · Oct 26
666.34K
Avg daily vol (3M)
14.76M
Analyst Estimates
Compare analyst forecasts for Vivos Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 15:34 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.14
|
-1.34
|
-0.75
|
4
|
-1.39
|
-1.39
|
-1.82
|
-1.15
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
21.79M
|
21.79M
|
21.79M
|
1
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.17
|
-0.82
|
-0.10
|
3
|
-0.79
|
-0.79
|
-0.84
|
-0.35
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
24.50M
|
34.09M
|
45.08M
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.54
|
-0.30
|
-0.12
|
4
|
-0.30
|
-0.30
|
-0.42
|
-0.25
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
5.48M
|
5.48M
|
5.48M
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.52
|
-0.25
|
-0.07
|
4
|
-0.25
|
-0.25
|
-0.36
|
-0.21
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
6.02M
|
6.02M
|
6.02M
|
1
|
— | — | — | — | — | — | — | — |